WAM to SeeSaw model for cancer therapy – overcoming LQM difficulties –

References

• Bando M, Kinugawa T, Manabe Y, Masugi M, Nakajima H, Suzuki K, Tsunoyama Y, Wada T, Toki H. 2019. Study of mutation from DNA to biological evolution. Int J Radiat Biol. 95(10):1390–1403.
   PubMed Web of Science ®Google Scholar
• Bando M, Manabe Y, Wada T. 2017. From DDREF to EDR–What the history of LNT indicates. Paper presented at 2017 ERPW Conference in Paris; France; 9–13.
   Google Scholar
• Bergonié J, Tribondeau L. 2003. Interpretation of some results from radiotherapy and an attempt to determine a rational treatment technique. Yale J Biol Med. 76(4–6):181–182. translated from Interprétation de quelques résultats de la radiothérapie et essai de fixation d’une technique rationnelle. Comptes rendus hebdomadaires de l’Académie des sciences (1906) 983–985.
   PubMedGoogle Scholar
• Bodgi L, Canet A, Pujo-Menjouet L, Lesne A, Victor JM, Foray N. 2016. Mathematical models of radiation action on living cells: From the target theory to the modern approaches. A historical and critical review. J Theor Biol. 394:93–101.
   PubMed Web of Science ®Google Scholar
• Borasi G. 2016. Comment on ‘Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach'. Phys Med Biol. 61(7):2967.
   PubMed Web of Science ®Google Scholar
• Borasi G, Nahum A. 2016. Modelling the radiotherapy effect in the reaction-diffusion equation. Phys Med. 32(9):1175–1179.
   PubMed Web of Science ®Google Scholar
• Chadwick KH, Leenhouts HP. 1973. A molecular theory of cell survival. Phys Med Biol. 18(1):78–87.
   PubMed Web of Science ®Google Scholar
• Curie M. 1929. Sur l’étude des courbes de probabilité relatives à l’action des rayons X sur les bacilles. Comptes Rendus L’Académie Des Sci. 188:202–204.
   Google Scholar
• Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, Demaria S. 2009. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res. 15(17):5379–5388.
   PubMed Web of Science ®Google Scholar
• Dhawan A, Kohandel M, Hill R, Sivaloganathan S. 2014. Tumour control probability in cancer stem cells hypothesis. PLoS One. 9(5):e96093.
   PubMed Web of Science ®Google Scholar
• Elkind MM, Whitmore GF, Alescio T. 1964. Actinomycin D: Suppression of recovery in X-irradiated mammalian cells. Science. 143(3613):1454–1457.
   PubMedGoogle Scholar
• Emami B, Woloschak G, Small W. Jr. 2015. Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance. Transl Cancer Res. 4(2):140–147.
   Web of Science ®Google Scholar
• Fowler JF. 1989. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62(740):679–694.
   PubMed Web of Science ®Google Scholar
• Fowler JF. 2010. 21 years of biologically effective dose. Br J Radiol. 83(991):554–568.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. 2018. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell Death 2018. Cell Death Differ. 25(3):486–541.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. 144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Harpold HLP, Alvord EC Jr, Swanson KR. 2007. The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol. 66(1):1–9.
   PubMed Web of Science ®Google Scholar
• Keinj R, Bastogne T, Vallois P. 2011. Multinomial model-based formulations of TCP and NTCP for radiotherapy treatment planning. J Theor Biol. 279(1):55–62.
   PubMed Web of Science ®Google Scholar
• Kelland LR, Steel GG. 1986. Dose-rate effects in the radiation response of four human tumour xenografts. Radiother Oncol. 7(3):259–268.
   PubMed Web of Science ®Google Scholar
• Kühleitner M, Brunner N, Nowak WG, Renner-Martin K, Scheicher K. 2019. Best fitting tumor growth models of the von Bertalanffy-PütterType. BMC Cancer. 19(1):683.
   PubMedGoogle Scholar
• Kumar S, Subramanian S. 2002. Mutation rates in mammalian genomes. Proc Natl Acad Sci USA. 99(2):803–808.
   PubMed Web of Science ®Google Scholar
• Lea DE. 1946. The inactivation of viruses by radiations. Br J Radiol. 19:205–212.
   PubMed Web of Science ®Google Scholar
• Magae J, Furukawa C, Ogata H. 2011. Dose-rate effect on proliferation suppression in human cell lines continuously exposed to γ rays. Radiat Res. 176(4):447–458.
   PubMed Web of Science ®Google Scholar
• Magae J, Hoshi Y, Furukawa C, Kawakami Y, Ogata H. 2003. Quantitative analysis of biological responses to ionizing radiation, including dose, irradiation time, and dose rate. Radiat Res. 160(5):543–548.
   PubMed Web of Science ®Google Scholar
• Manabe Y, Bando M. 2013. Comparison of data on mutation frequencies of mice caused by radiation with low dose model. J Phys Soc Jpn. 82(9):094004.
   Google Scholar
• Manabe Y, Ichikawa K, Bando M. 2012. A mathematical model for estimating biological damage caused by radiation. J Phys Soc Jpn. 81(10):104004.
   Google Scholar
• Manabe Y, Wada T, Tsunoyama Y, Nakajima H, Nakamura I, Bando M. 2015. Whack-a-mole model: towards a unified description of biological effects caused by radiation exposure. J Phys Soc Jpn. 84(4):044002.
   Google Scholar
• Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M, Yamada Y, et al. 1999. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res. 59(8):1911–1916.
   PubMed Web of Science ®Google Scholar
• Millar WT, Canney PA. 1993. Derivation and application of equations describing the effects of fractionated protracted irradiation, based on multiple and incomplete repair processes. Part I. Derivation of equations. Int J Radiat Biol. 64(3):275–291.
   PubMed Web of Science ®Google Scholar
• Mu X, Löfroth PO, Karlsson M, Zackrisson B. 2003. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. Radiother Oncol. 68(2):181–187.
   PubMed Web of Science ®Google Scholar
• Muller HJ. 1927. Artificial transmutation of the gene. Science. 66(1699):84–87.
   PubMedGoogle Scholar
• Muller HJ. 1932. Further studies on the nature and causes of gene mutations. Proceedings of the 6th International Congress of Genetics; Ithaca, New York 1: 213–255.
   Google Scholar
• Naderi S, Hunton IC, Wang JY. 2002. Radiation dose-dependent maintenance of G(2) arrest requires retinoblastoma protein. Cell Cycle. 1(3):193–200.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Furukawa C, Chang YC, Ogata H, Magae J. 2017. Delayed growth suppression and radioresistance induced by long-term continuous gamma irradiation. Radiat Res. 188(2):181–190.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Mizuta N, Sakaguchi K, Fujiwara I, Mizuta M, Furukawa C, Chang YC, Magae J. 2007. Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity. J Antibiot (Tokyo). 60(11):682–689.
   PubMed Web of Science ®Google Scholar
• Nakamura I, Manabe Y, Bando M. 2014. Reaction rate theory of radiation exposure and scaling hypothesis in mutation frequency. J Phys Soc Jpn. 83(11):114003.
   Google Scholar
• Nuraini R, Widita R. 2019. Tumor control probability (TCP) and normal tissue complication probability (NTCP) with consideration of cell biological effect. J Phys Conf Ser. 1245:012092.
   Google Scholar
• O’Rourke SFC, McAneney H, Hillen T. 2009. Linear quadratic and tumour control probability modelling in external beam radiotherapy. J Math Biol. 58(4–5):799–817.
   PubMed Web of Science ®Google Scholar
• Ogata H, Furukawa C, Kawakami Y, Magae J. 2005. A quantitative model for the evaluation of dose rates effects following exposure to low-dose gamma-radiation. Radioprotection. 40(2):191–202.
   Google Scholar
• Ponce Bobadilla AV, Maini PK, Byrne H. 2018. A stochastic model for tumour control probability that accounts for repair from sublethal damage. Math Med Biol. 35(2):181–202.
   PubMed Web of Science ®Google Scholar
• Prokopiou S, Moros EG, Poleszczuk J, Caudell J, Torres-Roca JF, Latifi K, Lee JK, Myerson R, Harrison LB, Enderling H. 2015. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Radiat Oncol. 10(1):159.
   PubMedGoogle Scholar
• Rockne R, Rockhill JK, Mrugala M, Spence AM, Kalet I, Hendrickson K, Lai A, Cloughesy T, Alvord EC, Jr, Swanson KR. 2010. Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach. Phys Med Biol. 55(12):3271–3285.
   PubMed Web of Science ®Google Scholar
• Rühm W, Azizova TV, Bouffler SD, Little MP, Shore RE, Walsh L, Woloschak GE. 2015. Dose-rate effects in radiation biology and radiation protection. Ann Icrp. 45(1_suppl):262–279.
   Google Scholar
• Rühm W, Woloschak GE, Shore RE, Azizova TV, Grosche B, Niwa O, Akiba S, Ono T, Suzuki K, Iwasaki T, et al. 2015. Dose and dose-rate effects of ionizing radiation: a discussion in the light of radiological protection. Radiat Environ Biophys. 54(4):379–401.
   PubMed Web of Science ®Google Scholar
• Russell WL. 1951. X-ray-induced mutations in mice. Cold Spring Harb Symp Quant Biol. 16:327–336.
   PubMedGoogle Scholar
• Russell WL. 1963. The effect of radiation dose rate and fractionation on mutation mice. In: Sobels FH, editor. Repair from genetic radiation damage. Oxford: Pergamon Press; p. 205–217, 231–235.
   Google Scholar
• Russell WL. 1965. Studies in mammalian radiation genetics. Nucleonics. 23(1):53–56, 62.
   Google Scholar
• Russell WL, Kelly EM. 1982a. Specific-locus mutation frequencies in mouse stem-cell spermatogonia at very low radiation dose rates. Proc Natl Acad Sci U S A. 79(2):539–541.
   PubMed Web of Science ®Google Scholar
• Russell WL, Kelly EM. 1982b. Mutation frequencies in male mice and the estimation of genetic hazards of radiation in men. Proc Natl Acad Sci U S A. 79(2):542–544.
   PubMed Web of Science ®Google Scholar
• Russell WL, Russell LB, Kelly EM. 1958. Radiation dose rate and mutation frequency. Science. 128(3338):1546–1550.
   PubMed Web of Science ®Google Scholar
• Sachs RK, Hlatky LR, Hahnfeldt P. 2001. Simple ODE models of tumor growth and anti-angiogenic or radiation treatment. Mathematic Comput Model. 33(12–13):1297–1305.
   Google Scholar
• Shimura T, Hamada N, Sasatani M, Kamiya K, Kunugita N. 2014. Nuclear accumulation of cyclin D1 following long-term fractionated exposures to low-dose ionizing radiation in normal human diploid cells. Cell Cycle. 13(8):1248–1255.
   PubMed Web of Science ®Google Scholar
• Shuryak I, Carlson DJ, Brown JM, Brenner DJ. 2015. High-dose and fractionation effects in stereotactic radiation therapy: analysis of tumor control data from 2965 patients. Radiother Oncol. 115(3):327–334.
   PubMed Web of Science ®Google Scholar
• Sobels FH. 1963. Repair and differential radiosensitivity in developing germ cells of Drosophila males. In: Sobels FH, editor. Repair from genetic radiation damage. Oxford: Pergamon Press; p. 179–197.
   Google Scholar
• Sottoriva A, Verhoeff JJC, Borovski T, McWeeney SK, Naumov L, Medema JP, Sloot PMA, Vermeulen L. 2010. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res. 70(1):46–56.
   PubMed Web of Science ®Google Scholar
• Steel GG, McMillan TJ, Peacock JH. 1989. The 5Rs of radio-biology. Int J Radiat Biol. 56(6):1045–1048.
   PubMed Web of Science ®Google Scholar
• Sunassee ED, Tan D, Ji N, Brady R, Moros EG, Caudell JJ, Yartsev S, Enderling H. 2019. Proliferation saturation index in an adaptive Bayesian approach to predict patient-specific radiotherapy responses. Int J Radiat Biol. 95(10):1421–1426.
   PubMed Web of Science ®Google Scholar
• Tariq I, Chen T, Kirkby NF, Jena R. 2016. Modelling and Bayesian adaptive prediction of individual patients' tumour volume change during radiotherapy. Phys Med Biol. 61(5):2145–2161.
   PubMed Web of Science ®Google Scholar
• Tobias CA. 1985. The repair-misrepair model in radiobiology: comparison to other models. Radiat Res Suppl. 8:S77–S95.
   PubMedGoogle Scholar
• Tsunoyama Y, Suzuki K, Masugi-Tokita M, Nakajima H, Manabe Y, Wada T, Bando M. 2019. Verification of a dose rate-responsive dynamic equilibrium model on radiation-induced mutation frequencies in mice. Int J Radiat Biol. 95(10):1414–1420.
   PubMed Web of Science ®Google Scholar
• van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP. 2018. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol. 13(1):96.
   PubMedGoogle Scholar
• Vogin G, Foray N. 2013. The law of Bergonié and Tribondeau: a nice formula for a first approximation. Int J Radiat Biol. 89(1):2–8.
   PubMed Web of Science ®Google Scholar
• Wada T, Manabe Y, Nakamura I, Tsunoyama Y, Nakajima H, Bando M. 2016. Dose and dose-rate dependence of mutation frequency under long-term exposure - a new look at DDREF from WAM model. J Nucl Sci Technol. 53(11):1824–1830.
   Web of Science ®Google Scholar
• Watanabe Y, Dahlman EL, Leder KZ, Hui SK. 2016. A mathematical model of tumor growth and its response to single irradiation. Theor Biol Med Model. 13:6.
   PubMed Web of Science ®Google Scholar
• Zaider M, Minerbo GN. 2000. Tumour control probability: a formulation applicable to any temporal protocol of dose delivery. Phys Med Biol. 45(2):279–293.
   PubMed Web of Science ®Google Scholar